Evidence map›Paper›PMID 22499558›Full record

ArticleAmerican journal of medical genetics. Part C, Seminars in medical genetics2012

Network- and attribute-based classifiers can prioritize genes and pathways for autism spectrum disorders and intellectual disability.

Yan Kou, Catalina Betancur, Huilei Xu, Joseph D Buxbaum, Avi Ma'ayan

Abstract read
In one paragraph

Article in American journal of medical genetics. Part C, Seminars in medical genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yan KouDepartment of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1668, New York, NY 10029, USA.
Catalina Betancur
Huilei Xu
Joseph D Buxbaum
Avi Ma'ayan

Funding

ZIPRASIDONE (GEODON) AUGMENTATION IN SEROTONIN REUPTAKE INHIBITOR-RESISTANT OBM01RR000071 · NCRR · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI NEWCORN, JEFFREY H · 1985 to 2009
$41.5M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI SCHIMMING, CORBETT · 1985 to 2019
$37.9M
System Biology Center in New YorkP50GM071558 · NIGMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZAPH, SUSANA NEVES · 2007 to 2017
$22.8M
QUANTITATIVE ANALYSIS OF MICROVASCULAR CHANGES IN THE AGING BRAINP01AG002219 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI HAROUTUNIAN, VAHRAM · 1985 to 2009
$19.2M
White Matter Abnormalities in SchizophreniaP50MH066392 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BUXBAUM, JOSEPH D. · 2002 to 2012
$18.6M
STUDIES OF CHOLINERGIC SYSTEMS AND AMYLOIDOGENESISP01AG010491 · NIA · THOMAS JEFFERSON UNIVERSITY · PI GANDY, SAMUEL E. · 1991 to 2009
$11.1M
MANAGEMENT/STATISTICS COREU54MH066673 · NIMH · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI HOLLANDER, ERIC · 2003 to 2007
$7.7M
Role of HIPK2 in Kidney Tubulointerstitial InjuryR01DK088541 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HE, JOHN CIJIANG · 2010 to 2019
$4.0M
Identifying therapeutic targets for autism using Shank3-deficient miceR01MH093725 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUXBAUM, JOSEPH D. · 2011 to 2015
$2.5M
A Chemical Biology Network for Personalized MedicineRC2LM010994 · NLM · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CARDOZO, TIMOTHY J, MA'AYAN, AVI · 2010 to 2010
$2.1M
FUNCTION OF THE FE65/APP COMPLEXR01AG021792 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BUXBAUM, JOSEPH D. · 2003 to 2007
$1.7M
3/5-Elucidating the Genetic Architecture of Autism by Deep Genomic SequencingR01MH089025 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BUXBAUM, JOSEPH D. · 2009 to 2010
$1.4M
Autism Speaks AS6693Autism Speaks AS7457NCRR NIH HHS M01 RR000071NIA NIH HHS P01 AG002219NIA NIH HHS P01 AG010491NIA NIH HHS P50 AG005138NIA NIH HHS R01 AG014996NIA NIH HHS R01 AG015801NIA NIH HHS R01 AG021792NIDDK NIH HHS R01 DK088541NIDDK NIH HHS R01DK088541-01A1NIGMS NIH HHS P50 GM071558NIGMS NIH HHS P50GM071558-03NIGMS NIH HHS R01 GM098316NIMH NIH HHS P50 MH066392NIMH NIH HHS R01 MH089025NIMH NIH HHS R01MH089025-02NIMH NIH HHS R01 MH093725NIMH NIH HHS R56 MH097849NIMH NIH HHS U54 MH066673NLM NIH HHS RC2 LM010994NLM NIH HHS RC2LM010994-01
6 · The paper itself

Abstract

Autism spectrum disorders (ASD) are a group of related neurodevelopmental disorders with significant combined prevalence (∼1%) and high heritability. Dozens of individually rare genes and loci associated with high-risk for ASD have been identified, which overlap extensively with genes for intellectual disability (ID). However, studies indicate that there may be hundreds of genes that remain to be identified. The advent of inexpensive massively parallel nucleotide sequencing can reveal the genetic underpinnings of heritable complex diseases, including ASD and ID. However, whole exome sequencing (WES) and whole genome sequencing (WGS) provides an embarrassment of riches, where many candidate variants emerge. It has been argued that genetic variation for ASD and ID will cluster in genes involved in distinct pathways and protein complexes. For this reason, computational methods that prioritize candidate genes based on additional functional information such as protein-protein interactions or association with specific canonical or empirical pathways, or other attributes, can be useful. In this study we applied several supervised learning approaches to prioritize ASD or ID disease gene candidates based on curated lists of known ASD and ID disease genes. We implemented two network-based classifiers and one attribute-based classifier to show that we can rank and classify known, and predict new, genes for these neurodevelopmental disorders. We also show that ID and ASD share common pathways that perturb an overlapping synaptic regulatory subnetwork. We also show that features relating to neuronal phenotypes in mouse knockouts can help in classifying neurodevelopmental genes. Our methods can be applied broadly to other diseases helping in prioritizing newly identified genetic variation that emerge from disease gene discovery based on WES and WGS.

Indexed as

Signal TransductionChildChild Development Disorders, PervasiveGene Regulatory NetworksGenetic MarkersGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansIntellectual DisabilityPhenotypeGenetic Markers

Identifiers

PMID22499558
PMCPMC3505691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.